Loading…
Champions Oncology, Inc. is projected to rise to $6.51 by 2027, a +12% move from its current price of $5.82. CSBR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.65 | $5.82 | $6.00 | +0.05% |
| Jul 14 | $5.58 | $5.83 | $6.08 | +0.09% |
| Jul 15 | $5.53 | $5.83 | $6.14 | +0.14% |
| Jul 16 | $5.49 | $5.83 | $6.20 | +0.18% |
| Jul 17 | $5.45 | $5.83 | $6.24 | +0.23% |
| Jul 18 | $5.42 | $5.84 | $6.29 | +0.27% |
| Jul 19 | $5.39 | $5.84 | $6.33 | +0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.39 | $5.84 | $6.33 | +0.32% |
| Week 2 | $5.23 | $5.86 | $6.56 | +0.64% |
| Week 3 | $5.11 | $5.88 | $6.75 | +0.96% |
| Week 4 | $5.02 | $5.89 | $6.92 | +1.29% |
| Week 5 | $4.94 | $5.91 | $7.08 | +1.61% |
| Week 6 | $4.87 | $5.93 | $7.22 | +1.94% |
| Week 7 | $4.81 | $5.95 | $7.36 | +2.26% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Champions Oncology, Inc. is a technology-enabled research company that provides technology solutions for drug discovery and development in the United States. It operates in the Healthcare category with a focus on oncology research solutions and data offerings.
Champions Oncology, Inc. (CSBR) currently trades at $5.76 and has a market capitalization of $79.99M. It ranks 4225 in size among public companies.
A major floor 16.3% below — a decisive break under it would weaken the trend.
The nearest floor, 3.1% below — buyers have tended to step in here.
The nearest ceiling, 18.2% above — a clean break opens room to run.
A major ceiling 26.3% above — clearing it would confirm fresh momentum.
Key CSBR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CSBR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.89 | Sell | $5.90 | Sell |
| MA 10 | $6.05 | Sell | $5.98 | Sell |
| MA 20 | $6.22 | Sell | $6.05 | Sell |
| MA 50 | $6.04 | Sell | $6.06 | Sell |
| MA 100 | $5.98 | Sell | $6.13 | Sell |
| MA 200 | $6.34 | Sell | $6.32 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.32 | Neutral |
| Stoch RSI (14) | 12.35 | Buy |
| CCI (20) | -103.08 | Sell |
| Williams %R (14) | -93.10 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | -6.58 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 6.90 | Buy |
| TRIX (15) | 0.04 | Buy |
| Awesome (5,34) | -0.17 | Sell |
| Ultimate (7,14,28) | 36.87 | Neutral |
| Momentum (10) | -0.26 | Sell |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 5.85 | Sell |
| ADX (14) | 11.85 | Neutral |
| ATR (14) | 0.16 | Info |
The 30-day technical picture is bearish. RSI14 is 40 and the stock trades with a sentiment labeled as BEARISH.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.64 | $5.82 | $7.70 | 0% | Neutral | |
| $5.13 | $6.51 | $8.78 | +12% | Neutral | |
| $4.78 | $6.26 | $8.79 | +8% | Neutral | |
| $5.66 | $7.61 | $11.03 | +31% | Bullish | |
| $6.88 | $9.47 | $14.09 | +63% | Bullish | |
| $7.28 | $10.24 | $15.58 | +76% | Bullish | |
| $8.22 | $11.79 | $18.32 | +103% | Bullish | |
| $8.26 | $12.06 | $19.10 | +107% | Bullish | |
| $8.04 | $11.96 | $19.26 | +105% | Bullish | |
| $8.74 | $13.22 | $21.64 | +127% | Bullish | |
| $12.17 | $19.87 | $34.76 | +241% | Bullish | |
| $23.18 | $43.35 | $83.50 | +645% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.64 | $5.82 | $6.87 | +0.00% |
| August 2026 | $4.99 | $5.90 | $7.19 | +1.42% |
| September 2026 | $5.09 | $6.07 | $7.48 | +2.79% |
| October 2026 | $4.96 | $5.96 | $7.42 | -1.84% |
| November 2026 | $4.90 | $5.92 | $7.43 | -0.69% |
| December 2026 | $5.00 | $6.08 | $7.70 | +2.73% |
Click any year to see its month-by-month CSBR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Champions Oncology, Inc.'s 2026 outlook centres on $5.82, within a $5.64 to $7.70 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, CSBR could reach as high as $8.78, with a base case around $6.51 and support toward $5.13 — roughly +12% from $5.82. Price action looks broadly range-bound.
Expect CSBR to range from $4.78 to $8.79 through 2028. The $6.26 average target implies a +8% move from current prices. That is -4% versus the projected 2027 average. A consolidation phase looks the most probable path here.
The CSBR price prediction for 2029 points to an average of $7.61 (low $5.66, high $11.03) — a potential gain of +31% on today's $5.82. Momentum favours further upside here.
In 2030, CSBR is projected to trade between $6.88 and $14.09, averaging $9.47 — a potential gain of +63% from today's $5.82. That is up +24% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Champions Oncology, Inc.'s 2031 outlook centres on $10.24, within a $7.28 to $15.58 range. That is up +8% on the projected 2030 average. That marks a +76% change versus current levels. Momentum favours further upside here.
By 2032, CSBR could reach as high as $18.32, with a base case around $11.79 and support toward $8.22 — roughly +103% from $5.82. Buyers look set to stay in control over this stretch.
Expect CSBR to range from $8.26 to $19.10 through 2033. The $12.06 average target implies a +107% move from current prices. That is up +2% on the projected 2032 average. Momentum favours further upside here.
The CSBR price prediction for 2034 points to an average of $11.96 (low $8.04, high $19.26) — a potential gain of +105% on today's $5.82. Buyers look set to stay in control over this stretch.
In 2035, CSBR is projected to trade between $8.74 and $21.64, averaging $13.22 — a potential gain of +127% from today's $5.82. That is up +11% on the projected 2034 average. Momentum favours further upside here.
Champions Oncology, Inc.'s 2040 outlook centres on $19.87, within a $12.17 to $34.76 range. That is up +50% on the projected 2035 average. That marks a +241% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, CSBR could reach as high as $83.50, with a base case around $43.35 and support toward $23.18 — roughly +645% from $5.82. Momentum favours further upside here.
Investing $1,000 in CSBR today (≈ 171.821306 CSBR) could be worth
$7,447.93
+$6,447.93 (+645%) by 2050 · US Dollar
Based on the average projected CSBR price of $43.35 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CSBRwould be worth at today's price.
$1,000 invested in CSBR on Jul 10, 2025 (≈ 113.507373 CSBR) would be worth
$660.61
-$339.39 (-33.9%) today · 0.66× · US Dollar
Based on a CSBR entry price of $8.81 vs. today's $5.82.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.76 | $1,010.42 | +1.0% |
| 1 month ago | $5.72 | $1,017.48 | +1.7% |
| 3 months ago | $5.75 | $1,012.17 | +1.2% |
| 6 months ago | $6.72 | $866.07 | -13.4% |
| 1 year ago | $8.81 | $660.61 | -33.9% |
| All time (5.0y) ago | $9.46 | $615.22 | -38.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CSBR forecast.
Our base-case forecast reaches $12.00 around 2033.
Implied market cap at $12.00: $166.64M
The multi-year forecast shows a bullish shift into the later years. 2026 avg is $5.76 with ROI 0 and sentiment NEUTRAL, while 2027 avg is $6.35 with ROI 10.2 and sentiment NEUTRAL. 2028 avg is $6.19 (ROI 7.5, NEUTRAL) and 2029 avg is $7.59 (ROI 31.8, BULLISH).
2030 avg is $9.42 (ROI 63.6, BULLISH) with min $6.72 and max $14.30. 2031 avg is $10.27 (ROI 78.3, BULLISH), 2032 avg is $11.89 (ROI 106.5, BULLISH), 2033 avg is $11.99 (ROI 108.2, BULLISH), 2034 avg is $11.88 (ROI 106.3, BULLISH), 2035 avg is $13.19 (ROI 129, BULLISH). 2040 avg is $20.02 (ROI 247.6, BULLISH) and 2050 avg is $44.05 (ROI 664.7, BULLISH).
These are estimates, not guarantees, and reflect a long-term upside with inherent uncertainty.
Tap a question to reveal the answer.
2030 avg $9.42; min $6.72; max $14.30; ROI 63.6; sentiment BULLISH.
Forecasts show potential upside with a path to higher prices in later years (e.g., 2027 avg $6.35, 2029 avg $7.59, 2030 avg $9.42, 2040 avg $20.02, 2050 avg $44.05) but these are estimates and not guarantees.
Yes, the forecast for 2030 lists a max of $14.30 with a 2030 min of $6.72 and an avg of $9.42; ROI 63.6 and sentiment BULLISH.
2040 min $11.80; avg $20.02; max $36.08; ROI 247.6; sentiment BULLISH.
Current price $5.76; Market cap $79.99M.
Champions Oncology, Inc. Community Discussion
0Share your Champions Oncology, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.